Establishing Normal Values for Neuropsychological Testing in HIV-negative Thais
1 other identifier
observational
494
1 country
1
Brief Summary
The purpose of this study is to establish normal values for neuropsychological testing in HIV negative Thais stratified by age (1 decade) and education (no certificate or primary school certificate, less than high school certificate or vocational certificate, high school certificate or higher vocational certificate or diploma, Bachelor degree or higher.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Feb 2008
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2008
CompletedFirst Submitted
Initial submission to the registry
July 8, 2008
CompletedFirst Posted
Study publicly available on registry
July 11, 2008
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2013
CompletedSeptember 26, 2014
September 1, 2014
5.8 years
July 8, 2008
September 25, 2014
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
To establish normal values for neuropsychological testing in HIV negative Thais stratified by age (1 decade) and education
July 31, 2014
Secondary Outcomes (1)
To estimate the learning effect on these test at 6 months and 12 months.
July 31, 2014
Eligibility Criteria
HIV-negative Thais
You may qualify if:
- Age 20-69
- Male or female
- Negative HIV antibody at screening
- Have the ability to understand the study and signed the informed consent form
You may not qualify if:
- Head injury with loss of consciousness greater than 1 hour
- Current or past illicit drug use or positive drug screen for amphetamine, methamphetamines, cocaine, marijuana, or narcotics
- Severe illness within 30 days prior to entry
- Current or recent fevers or meningeal signs.
- History of pre-existing neurologic disease to include stroke, multiple sclerosis or autoimmune disease.
- active major depression will be excluded as well - patients with past depression that is controlled and patients with or minor depressive symptoms will be allowed to enroll.
- Known learning disability including dyslexia
- Confusion or other signs and symptoms of metabolic encephalopathy or delirium
- Focal neurological deficit on examination
- Examining physician's concern that participant may not be able to complete visit requirements.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
SEARCH Thailand
Bangkok, Bangkok, 10330, Thailand
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Victor - Valcour, M.D.
University of Hawaii
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assoc.Prof.
Study Record Dates
First Submitted
July 8, 2008
First Posted
July 11, 2008
Study Start
February 1, 2008
Primary Completion
December 1, 2013
Study Completion
December 1, 2013
Last Updated
September 26, 2014
Record last verified: 2014-09